TELA Bio (TELA) Capital Expenditures Growth (1y) (2019 - 2026)
Powered by 
Analysis
TELA Bio (TELA) Capital Expenditures Growth (1y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.74 Bn | 175.14 Bn | 7.27 Bn | -1.00% |
| 2 | Intuitive Surgical | 127.56 Bn | 122.34 Bn | 1.96 Bn | -27.50% |
| 3 | Medtronic | 116.90 Bn | 108.08 Bn | 6.34 Bn | -0.20% |
| 4 | Stryker | 103.85 Bn | 100.37 Bn | 4.50 Bn | 10.38% |
| 5 | Boston Scientific | 63.70 Bn | 63.16 Bn | 3.85 Bn | 24.20% |
| 6 | Edwards Lifesciences | 49.88 Bn | 45.63 Bn | 1.35 Bn | 35.70% |
| 7 | Alcon | 33.04 Bn | 31.59 Bn | 1.68 Bn | 5.88% |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | -9.99% |
| 9 | Steris | 20.65 Bn | 20.17 Bn | 684.20 Mn | -6.52% |
| 10 | TELA Bio | 48.87 Mn | 18.44 Mn | 13.94 Mn | -48.25% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -48.25% |
| Mar 31, 2026 | 271.88% |
| Dec 31, 2025 | -65.53% |
| Sep 30, 2025 | 72.95% |
| Jun 30, 2025 | -61.87% |
| Mar 31, 2025 | -89.47% |
| Dec 31, 2024 | 28.78% |
| Sep 30, 2024 | -8.96% |
| Jun 30, 2024 | 90.45% |
| Mar 31, 2024 | 164.35% |
| Dec 31, 2023 | 345.65% |
| Sep 30, 2023 | -53.79% |
| Jun 30, 2023 | -21.50% |
| Mar 31, 2023 | -65.77% |
| Dec 31, 2022 | -84.08% |
| Sep 30, 2022 | 2.47% |
| Jun 30, 2022 | 506.06% |
| Mar 31, 2022 | 1,427.27% |
| Dec 31, 2021 | 660.53% |
| Sep 30, 2021 | 757.58% |